Northwestern Mutual Wealth Management CO Iovance Biotherapeutics, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $112 Billion
- Q3 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 2,189 shares of IOVA stock, worth $16,329. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,189
Previous 1,880
16.44%
Holding current value
$16,329
Previous $15,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IOVA
# of Institutions
313Shares Held
237MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$204 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$199 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$179 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$158 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$98.5 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.18B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...